Skip to main content


Update on service during Covid-19 pandemic

The Covid-19 pandemic has placed unprecedented demands on UHS pathology, as we respond to the reconfiguration of services required to support the NHS. Clinicians within UHS pathology are continuously reviewing current service provision to meet the needs of patients, ensuring that testing required for immediate patient management is prioritised. It follows that some lower priority work will have to be deferred.

Due to the rapid pace of change it is not possible to give full details of the services affected at any moment in time, but examples of services that could be deferred can be found in the RCPath guidance (prepared in association with NHSI&E and the professional bodies) at the link below.

Guidance for pathology testing prioritisation

As always, clinicians are available to offer a clinical advisory service. Contact details are published in the laboratory handbooks on our website.


Laboratory medicine: clinical biochemistry, haematology, immunology, molecular pathology and transfusion

Laboratory medicine provides a comprehensive range of pathology services to the Trust, general practitioners and also to other external NHS and private sector organisations. It consists of clinical biochemistry, haematology, blood transfusion, immunology and molecular pathology departments.

Microbiology: bacteriology, virology, serology and molecular epidemiology

The laboratory provides a full microbiological service for the diagnosis of infection, which includes bacteriology, virology, serology, parsitology, mycology, molecular epidemiological studies and environmental microbiology to UHS, other NHS Trusts, general practitioners and local authorities.

Cellular pathology, histopathology, neuropathology, cytopathology, mortuary, Biomedical Imaging Unit